Related Experiment Video
Updated: Jul 21, 2025

Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study
Monica State1,2, Paul Balanescu2, Theodor Voiosu1,2
1Gastroenterology Department, Colentina Clinical Hospital, 020125 Bucharest, Romania.
Histologic remission in ulcerative colitis is low in real-world settings. While quality of life and inflammatory markers show associations, they don't reliably predict deeper healing, suggesting a role for lymphocyte-targeted therapies.
Area of Science:
- Gastroenterology
- Immunology
- Clinical Medicine
Background:
- Histologic activity is an emerging goal in ulcerative colitis (UC) management, potentially serving as an adjunct to mucosal healing.
- This study investigates rates of mucosal and histologic remission and their predictors in UC patients.
Purpose of the Study:
- To determine the rates of mucosal and histologic remission in a cohort of ulcerative colitis patients.
- To identify potential predictors of mucosal and histologic healing.
- To explore the role of lymphocyte populations in ulcerative colitis pathogenesis.
Main Methods:
- Retrospective analysis of a prospective cohort of UC patients.
- Mucosal healing defined as Mayo endoscopic score = 0.
- Assessment of clinical remission, SIBDQ scores, CRP levels, corticotherapy use, and intraepithelial lymphocyte (IEL) counts (CD8+ and CD4+).
Main Results:
- Mucosal healing was observed in 26% of study visits, with 66% of those achieving histologic remission.
- Univariate analysis suggested associations between mucosal healing and sustained clinical remission, SIBDQ scores, CRP levels, and absence of corticotherapy.
- Logistic regression revealed no significant predictors for mucosal or histologic healing; however, CD8+ IELs were significantly higher than CD4+ IELs during both active disease and mucosal healing.
Conclusions:
- Mucosal and histologic remission rates are low in clinical practice.
- While quality of life and inflammatory markers correlate with healing, they are not reliable predictors of histologic remission.
- Increased CD8+ lymphocyte presence suggests a significant role in UC pathogenesis and potential therapeutic targets.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Endoscopic Procedures II: Colonoscopy
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...

